World Journal of Gastroenterology - Baishideng Publishing Group

BPG is committed to discovery and dissemination of knowledge

Cited by in CrossRef

For:	Feng DY, Sun Y, Cheng RX, Ouyang XM, Zheng H. Effect of hepatitis C virus nonstructural protein NS3 on proliferation and MAPK phosphorylation of normal hepatocyte line. World J Gastroenterol 2005; 11(14): 2157-2161 [PMID: 15810084 DOI: 10.3748/wjg.v11.i14.2157]
URL:	https://www.wjgnet.com/1007-9327/full/v11/i14/2157.htm

(0) (0) (0) (4100) (25)

Number	Citing Articles
1	Aqsa Ikram, Bisma Rauff, Badr Alzahrani, Faryal Mehwish Awan, Ayesha Obaid, Anam Naz, Salik Javed Kakar, Hussnain Ahmed Janjua. Integrated analysis to study the interplay between post-translational modifications (PTM) in hepatitis C virus proteins and hepatocellular carcinoma (HCC) development. Scientific Reports 2022; 12(1) doi: 10.1038/s41598-022-19854-6
2	Urania Georgopoulou, Alexios Dimitriadis, Pelagia Foka, Eirini Karamichali, Avgi Mamalaki. Hepcidin and the iron enigma in HCV infection. Virulence 2014; 5(4) doi: 10.4161/viru.28508
3	Mohammad Irshad, Priyanka Gupta, Khushboo Irshad. Molecular basis of hepatocellular carcinoma induced by hepatitis C virus infection. World Journal of Hepatology 2017; 9(36): 1305-1314 doi: 10.4254/wjh.v9.i36.1305 Abstract(1644) \| Core Tip(1615) \| Full Article(HTML)(8437) \| Full Article (PDF)-1515K(1216) \| Full Article (Word)-631K(355) \| Audio-413K(47) \| Answering Reviewers-81K(385) \| Times Cited (72) \| Total Visits (10708) \| Open
4	Ben Ponvilawan, Thanitsara Rittiphairoj, Nipith Charoenngam, Pongprueth Rujirachun, Phuuwadith Wattanachayakul, Surapa Tornsatitkul, Patompong Ungprasert. Association Between Chronic Hepatitis C Virus Infection and Esophageal Cancer. Journal of Clinical Gastroenterology 2022; 56(1) doi: 10.1097/MCG.0000000000001532
5	Simmone D'souza, Keith CK Lau, Carla S Coffin, Trushar R Patel. Molecular mechanisms of viral hepatitis induced hepatocellular carcinoma. World Journal of Gastroenterology 2020; 26(38): 5759-5783 doi: 10.3748/wjg.v26.i38.5759 Abstract(1515) \| Core Tip(1454) \| Full Article(HTML)(28542) \| Full Article (PDF)-11962K(2503) \| Full Article (Word)-4186K(262) \| Audio-889K(60) \| Answering Reviewers-86K(323) \| Times Cited (239) \| Total Visits (33114) \| Open
6	Clara Balsano, Anna Alisi. Hepatitis C virus (HCV): an RNA virus with a pro-oncogenic potential. Digestive and Liver Disease 2007; 39 doi: 10.1016/S1590-8658(07)80010-7
7	. 2025; doi: 10.70675/2b3b9642zacd0z4687zac2bzd501590eebe4
8	Kung-Chia Young, Chyi-Huey Bai, Hui-Chen Su, Pei-Ju Tsai, Chien-Yu Pu, Chao-Sheng Liao, Yu-Min Lin, Hsin-Wen Lai, Lee-Won Chong, Yau-Sheng Tsai, Chiung-Wen Tsao. Fluoxetine a novel anti-hepatitis C virus agent via ROS-, JNK-, and PPARβ/γ-dependent pathways. Antiviral Research 2014; 110 doi: 10.1016/j.antiviral.2014.08.002
9	Debojyoti Halder, Ashutosh Gupta, Subhasis Chakraborty, Partha Roy, Kalyan Kumar Sen. Upgraded theragnostic strategies of multivariate nano gold in the management of hepatocellular carcinoma. Nano-Structures & Nano-Objects 2024; 40 doi: 10.1016/j.nanoso.2024.101342
10	Anuradha Balasubramanian, Jerome E. Groopman, Ramesh K. Ganju. Underlying Pathophysiology of HCV Infection in HIV-Positive Drug Users. Journal of Addictive Diseases 2008; 27(2) doi: 10.1300/J069v27n02_09
11	Dowluru S.V.G.K. Kaladhar, Tantravahi Srinivasan. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; doi: 10.1016/B978-0-323-98806-3.00005-2
12	Carole-Anne Martineau, Nathalie Rivard, Martin Bisaillon. From viruses to cancer: exploring the role of the hepatitis C virus NS3 protein in carcinogenesis. Infectious Agents and Cancer 2024; 19(1) doi: 10.1186/s13027-024-00606-2
13	Mohd Amir F. Abdullah, Sarah M. McWhirter, Zucai Suo. Modulation of Kinase Activities In Vitro by Hepatitis C Virus Protease NS3/NS4A Mediated-Cleavage of Key Immune Modulator Kinases. Cells 2023; 12(3) doi: 10.3390/cells12030406
14	K. Zscharnack, R. Kessler, F. Bleichert, J. P. Warnke, K. Eschrich. The PFKFB3 splice variant UBI2K4 is downregulated in high‐grade astrocytomas and impedes the growth of U87 glioblastoma cells. Neuropathology and Applied Neurobiology 2009; 35(6) doi: 10.1111/j.1365-2990.2009.01027.x
15	T. Vescovo, G. Refolo, G. Vitagliano, G.M. Fimia, M. Piacentini. Molecular mechanisms of hepatitis C virus–induced hepatocellular carcinoma. Clinical Microbiology and Infection 2016; 22(10) doi: 10.1016/j.cmi.2016.07.019
16	Zakaria Boulahtouf, Alessia Virzì, Thomas F. Baumert, Eloi R. Verrier, Joachim Lupberger. Signaling Induced by Chronic Viral Hepatitis: Dependence and Consequences. International Journal of Molecular Sciences 2022; 23(5) doi: 10.3390/ijms23052787
17	Ziv Ben Ari, Ella Weitzman, Michal Safran. Oncogenic Viruses and Hepatocellular Carcinoma. Clinics in Liver Disease 2015; 19(2) doi: 10.1016/j.cld.2015.01.006
18	Nisha Sahu, Samrat Rakshit, L.V.K.S. Bhaskar. Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma. 2022; doi: 10.1016/B978-0-323-98806-3.00023-4
19	Jun-Wu Li, Ke Li, Jing Jiang, Xiao-Liang Xu, Ze-Qi Huang. Construction of eukaryotic expression plasmid containing HCV NS3 segment and protein expression in human HL-7702 hepatocytes. World Journal of Gastroenterology 2006; 12(7): 1038-1042 doi: 10.3748/wjg.v12.i7.1038 Abstract(1249) \| Core Tip(1046) \| Full Article(HTML)(2748) \| Full Article (PDF)-744K(482) \| Times Cited (2) \| Total Visits (3794) \| Open
20	Mohamed Hassan, Denis Selimovic, Abdelouahid El-Khattouti, Hanan Ghozlan, Youssef Haikel, Ola Abdelkader. Hepatitis C virus-host interactions: Etiopathogenesis and therapeutic strategies. World Journal of Experimental Medicine 2012; 2(2): 7-25 doi: 10.5493/wjem.v2.i2.7 Abstract(2380) \| Core Tip(1478) \| Full Article(HTML)(8748) \| Full Article (PDF)-1168K(989) \| Times Cited (3) \| Total Visits (10402) \| Open
21	. 2021; doi: 10.70675/a2b1195ez9acdz4848za284z48d03d642274
22	Tomomi Kogiso, Takaomi Sagawa, Kazuhisa Kodama, Makiko Taniai, Satoshi Katagiri, Hiroto Egawa, Masakazu Yamamoto, Katsutoshi Tokushige. Hepatocellular carcinoma after direct‐acting antiviral drug treatment in patients with hepatitis C virus. JGH Open 2019; 3(1) doi: 10.1002/jgh3.12105
23	X. B. Pan, L. Wei, H. S. Chen, F. Liu, Y. Gao. Liver-derived cell lines QSG-7701 and HepG2 support different HBV replication patterns. Archives of Virology 2007; 152(6) doi: 10.1007/s00705-006-0927-4
24	Huanqin Li, Shumin Liu, Yun Lin, Xiongfei Shi, Na Du, Jing Yao, Ruiyang Liu, Yan Du, Kai Yang. Identification and Verification of Ubiquitin D as a Gene Associated with Hepatitis C Virus-Induced Hepatocellular Carcinoma. Intervirology 2022; 65(4) doi: 10.1159/000525543
25	Aldona Kasprzak, Agnieszka Adamek. Role of hepatitis C virus proteins (C, NS3, NS5A) in hepatic oncogenesis. Hepatology Research 2008; 38(1) doi: 10.1111/j.1872-034X.2007.00261.x